For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time vs placebo.

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist ...

Oral carbidopa-levodopa formulation improves sleep in Parkinson disease, particularly addressing sleep disturbances and ...

Get Instant Summarized Text (Gist) Levodopa, a dopamine-enhancing medication, may improve motivation in depression linked to high inflammation. Individuals with C-reactive protein (CRP) levels ...

Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.

Parkinson's disease cases are projected to surge by 112% globally by 2050, reaching 25.2 million. Early detection is crucial, ...

Part II of the MDS-UPDRS measures activities of daily living. Part III assesses motor symptoms including tremors, rigidity, ...

Shaking hands or tremors are a frequent symptom of Parkinson's, but not the only one. Read on as we debunk other myths.

King's College Hospital Dubai launches Foslevodopa treatment, transforming Parkinson's care for the youngest patient in MENA.